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ABSTRACT:
One quarter of cerebral infarctions are cryptogenic and most of these patients are young. Patent Foramen Ovale (PFO)
is found to be more prevalent in young persons with cryptogenic stroke and risk of stroke recurrence in such patients
ranges from as low as 2% per annum to as high as 12% per annum. Since patients with PFO and cryptogenic stroke
are young they need more effective ways to reduce risk of stroke recurrence hence percutaneous closure of PFO seems
reasonable approach to deal with this etiology of stroke in such population. We report four cases of cryptogenic stroke
in young Saudi patients. PFO closure was performed in all. After closure, none of them developed either recurrence of
symptoms or any complication on follow up for more than one year.
Conclusion: PFO closure can be considered for preventing stroke recurrence in selected young persons with both
cryptogenic stroke and PFO.
Keywords: Cryptogenic, Young, Stroke, PFO, Closure

INTRODUCTION: One quarter of cerebral infarctions is
cryptogenic and Patent Foramen Ovale (PFO) is highly
prevalent in such patients especially those less than 50
years. PFO is a persistent passage between two atria
and is visualized in about 25% of general population.
PFO is considered to cause stroke either by paradoxical
embolism or by in situ thrombus formation. Recently
published three randomized trials have demonstrated
efficacy of PFO closure in preventing stroke recurrence
in patients with PFO and cryptogenic cerebral
infarction. We report four cases of cryptogenic cerebral
infarction in young patients in whom PFO was found
and closure of PFO was performed with follow up.

unremarkable .His HbA1c was normal and lipid profile
revealed high cholesterol and LDL. His work up for
thrombophilia as well as autoimmune disease was
negative. His trans-esophageal echo showed Patent
Foramen Ovale. During hospitalization, his blood
pressure readings were within normal ranges. His PFO
was closed one week later without any complication.
He was discharged on dual antiplatelet therapy and
statin. He followed up in clinic for 14 months without
new neurologic symptoms or signs.
Case 2:
36 years old gentleman, smoker, no known medical
illness presented with complaint of left sided body
weakness. His neurologic examination revealed mild
weakness of left side involving face, arm and leg. His
MRI head showed acute infarction involving right
periventricular area. MR angiogram of head and neck
was unremarkable. His ECG showed normal sinus
rhythm. His lipid profile and HbA1c were normal. His
thrombophilic work up as well as autoimmune work up
was negative. His trans-esophageal echo showed PFO
with mobile interatrial septum. During hospitalization,

Case presentation
Case 1:
43 years old gentleman, smoker, no known medical
illness reported to emergency department complaining
of weakness of left side of body. His neurologic
examination revealed decreased sensation on left side
of body. MRI head showed acute infarction of right
thalamocapsular junction. CT angiogram of head and
neck as well as 24 hour holter monitoring were

PAKISTAN JOURNAL OF NEUROLOGICAL SCIENCES

24

VOL. 14 (2)

APRIL- JUNE 2019

his blood pressure readings were within normal ranges.
He underwent closure of PFO 10 days later without any
complication. He was discharged on dual antiplatelet
therapy for 6 months and statin. He was followed up in
clinic for 12 months without any complaints of
recurrence of symptoms.

Figure 1. a) Diffusion weighted imaging (DWI) and
adjusted Diffusion Coefficient (ADC) of case 1, showing
acute infraction of right thalamo-capsular junction/ b)
Diffusion weighted imaging (DWI) and adjusted
diffusion coefficient (ADC) of case 2, showing acute
infraction of right periventricular region. c) Diffusion
weighted imaging (DWI) and adjusted diffusion
coefficient (ADC) of caes 3, shwoing acute infraction of
posterior limb of left internal capsule.

Case 3:
44 years old gentleman, tobacco chewer, no previous
known medical illness came to emergency department
complaining of weakness of right side of body. His
neurologic examination was positive for ataxia of right
upper and lower limbs and mild right lower extremity
weakness. His head MRI showed acute infarction of
posterior limb of left internal capsule. MR angiograms
of head and neck as well as 24 hour holter monitoring
were unremarkable. His HbA1c was normal and lipid
profile showed high cholesterol and LDL. His
autoimmune works up as well as thrombophilic work up
were negative. His transesophageal echo showed PFO.
He was normotensive. He underwent percutaneous
closure of PFO. He was discharged on dual antiplatelet
therapy for 6 months and statin. He followed in clinic
for 12 months without recurrence of symptoms.

Discussion
Cryptogenic strokes comprise one fourth of all ischemic
strokes and most of them are embolic in nature.
Case-control studies have demonstrated that PFO is
more frequent in subjects with cryptogenic cerebral
infarction than in age-matched subjects without
cerebral infarction.1 The foramen ovale is passage that
exists in the wall between the two atria of every human
fetus. It normally shuts during infancy but in
approximately one quarter of general population it
remains patent2.In an autopsy based study, overall
incidence of PFO was 27% and incidence decreased
with increasing age whereas size of defect increased
with increased age.3In population based study
Meissner et al have reported that 24.3% of their
sample population had PFO.4 The correlation of PFO
with stroke was first described by Cohnheim in year
1877.5Meta-analysis of case-control studies has
demonstrated that likelihood of finding PFO was twice
in subjects with cerebral infarction as compared to
control subjects and this association was three times
more likely in group of subjects with cryptogenic
cerebral infarction whose ages were less than 55
years.6Similar findings have been reported in another
meta-analysis of case-control studies demonstrating
that likelihood of finding PFO in patients with stroke of
unknown etiology was three times higher as compared
to age matched control subjects and it increased to
fivefold in patients of young age group with cryptogenic
cerebral infarction.7 Prevalence of PFO in subjects with
cryptogenic stroke reaches up to 34% to 40%.7,8
Annual risk of stroke recurrence in patients with PFO
has been reported to be ranging from 2% over three
year follow up duration to as high as 12.5% at 3 years
follow up in high risk patients.9-13 Two possible
mechanisms have been hypothesized by which PFO can
cause stroke, one is susceptibility of such patients to
atrial arrhythmias with thrombus formation and other is
paradoxical embolization.14 Likelihood that PFO can be
cause of stroke increases as patient’s age decreases
as well as if conventional risk factors for stroke are
absent.15 Younger patients in whom usual risk factors
for stroke are not found, such subjects are much more

Case 4:
44 years old gentleman, non-smoker, hypertensive
presented to outpatient clinic with sudden onset left
sided weakness lasting 30 minutes. His neurologic
examination was unremarkable at time of presentation.
His non contrast CT scan of head was unremarkable.
His ultrasound Doppler of carotids and ECG were
unremarkable. MR or CT angiogram was not done. His
HbA1c was normal and lipid profile showed high LDL.
His echo showed Patent Foramen Ovale. He was
treated with dual antiplatelet therapy, statin and
anti-hypertensive medication. 2 weeks later, he
underwent percutaneous PFO closure and was kept on
dual antiplatelet therapy for 6 months then switched to
clopidogrel. He was followed up in clinic for 24 months
without any complication.
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Conclusion

likely to have PFO than those patients with usual risk
factors. Kent at al suggested 10-point Risk of
Paradoxical Embolism score (RoPE score) to divide
patients with cryptogenic stroke and PFO into high or
low likelihood proposing that PFO can be cause of
stroke or is incidental finding.16 This score uses
patient’s age, cortical infarction on neuroimaging and
conventional risk factors of stroke. Higher the RopE
score, higher likelihood that PFO can be cause of
stroke. Increased use of saline contrast TEE has
increased the frequency of detection of PFO in stroke
patients.Three randomized trials published previously
addressing hypothesis that PFO closure is better than
medical therapy in secondary stroke prevention came
out to be negative.17-19 However, recently published
three randomized trials addressing similar question
came out to be positive demonstrating that PFO closure
is better than medical therapy for secondary stroke
prevention in patients with stroke of unknown etiology
and PFO. In a randomized, multicentre trial PFO closure
along with antiplatelet therapy was found to be
significantly better for secondary stroke prevention in
patients with stroke whose stroke was attributed to PFO
with atrial septal aneurysm or large inter-atrial shunt as
compared to antiplatelet therapy alone(Hazard
ratio,0.03;95%
confidence
interval,0-0.26;
P<0.001).20Also,in extended follow up for a median
of 6 years of RESPECT trial cases, recurrence of
cerebral infarction was 45% less in patients with
cryptogenic stroke and PFO for whom PFO closure was
performed.21 REDUCE trial showed that patients with
cryptogenic stroke with PFO who underwent FO closure
had 67% lower risk of recurrent ischemic stroke during
a median follow up of 3.2 years (HR 0.23%, 95% CI
0.09 to 0.62; P=0.002).22 All of our cases were less
than 45 years of age and their routine stroke work up
including CT/MR angiogram of head and neck, 24 hour
holter monitor as well as work up for thrombophilia and
autoimmune diseases was negative. This fits into
description
of
cryptogenic
stroke.
Their
echocardiograms showed patent formen ovale. As
discussed above, there is strong association of PFO
with stroke in such patient population. Therefore, in our
cases PFO can be considered as likely source of stroke.
So, PFO closure was performed for our cases for
secondary stroke prevention. All our cases received
medical therapy along with PFO closure as was done in
recently published randomized trials of PFO closure.
None of our cases had either procedure related
complication or recurrence of stroke symptoms during
follow up period ranging from 12 months to 24 months.
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Patent foramen ovale can be a cause of stroke in young
patients in whom no other cause of stroke can be found
on work up. Recent literature has shown efficacy of PFO
closure in such patient population. Our cases also
demonstrate that PFO closure can be considered in
young patients with cryptogenic stroke for secondary
prevention of stroke.
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